KSL will be a featured exhibitor at our first international conference of the year: the 22nd Medlab Middle East on February 6-9, 2023

Research Showing Correlation Between COVID-19 Antibody Levels and Virus Neutralization Led to KSL’s COVID-19 Immune Index™ Antibody Test...

KSL launches first-of-its-kind antibody test, the COVID-19 Immune Index™ that detects one's immune response to COVID-19 vaccine or infection

KSL Diagnostics Launches Pop-Up COVID-19 Testing and Vaccination Site at Walden Galleria

KSL President and CEO, Kevin Lawson, named 2021 C-Level Executives Awards Honoree

KSL Diagnostic Develops COVID-19 Testing Network for the Erie County Department of Health (ECDOH)

UB CAT Approves KSL Diagnostics COVID-19 Risk Stratification in Vaccinated Individuals Project

Collaborative Study: Antibody Production Post COVID-19 Vaccines in Patients with Blood Disorder

KSL becomes the first A2LA ISO 15189 certified laboratory in New York State BUFFALO, NY—KSL Diagnostics has been certified by the...

The first commercial sqid-X system sale will be housed at KSL Diagnostics in Buffalo, NY. KSL is a partner of UB...

Beutner Laboratories will retain its identity and continue a long tradition of excellence in laboratory service.

KSL has developed diagnostic tests and is moving forward with clinical validation of prognostic tools that could improve patient care...

Exclusive deal with KSL Biomedical signals PredictImmune’s major move into North America Cambridge, UK — PredictImmune, developers of...